Market Tracker

01/23 3:10am ET

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

4.06
Delayed Data
As of Jan 20
 -0.03 / -0.73%
Today’s Change
3.78
Today|||52-Week Range
10.06
-1.69%
Year-to-Date
No recent news for Achillion Pharmaceuticals Inc.

Today’s Trading

Previous close4.09
Today’s open4.09
Day’s range4.02 - 4.11
Volume714,109
Average volume (3 months)2,023,963
Market cap$559.0M
Dividend yield--
Data as of 3:59pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+94.29%
Earnings growth (this year)-1,406.25%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales20.49
Price/Book1.24

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...-0.20-0.98%
FLXNFlexion Therapeutics...-0.06-0.32%
SCMPSucampo Pharmaceutic...-0.05-0.44%
HSKAHeska Corp+0.49+0.63%
Data as of 3:59pm ET, 01/20/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$66.1M
Annual profit (last year)-$5.0M
Net profit margin-7.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Executive VP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts